Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

Cited by (1,000)

Items 301–400 of 1,000

1. The FAST-ED App: A Smartphone Platform for the Field Triage of Patients With Stroke
   Raul G. Nogueira, Gisele Sampaio Silva, Fabrício Oliveira Lima, Yu‐Chih Yeh, Carol M. Fleming, Daniel Branco, Arthur H. Yancey, Jonathan J. Ratcliff, Robert Keith Wages, Earnest R. Doss et al. · 2017 · Stroke
2. New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)
   Rick H. van Gorp, Leon J. Schurgers · 2015 · Nutrients
3. Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral Anticoagulation
   Jeff S. Healey, Jason L. Martin, Andrew Duncan, Stuart J. Connolly, Andrew H. Ha, Carlos Arturo Morillo, Girish M. Nair, John W. Eikelboom, Syamkumar Divakaramenon, Hisham Dokainish · 2012 · Canadian Journal of Cardiology
4. Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation
   Yi‐Hsin Chan, Kun‐Chi Yen, Lai‐Chu See, Shang‐Hung Chang, Lung‐Sheng Wu, Hsin‐Fu Lee, Hui‐Tzu Tu, Yung‐Hsin Yeh, Chi-Tai Kuo · 2016 · Stroke
5. Thrombo-Embolism and Antithrombotic Therapy for Heart Failure in Sinus Rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis
   Gregory Y.H. Lip, Piotr Ponikowski, Felicita Andreotti, Stefan D. Anker, Gerasimos Filippatos, Shunichi Homma, João Morais, Patrick M. Pullicino, Lars Hvilsted Rasmussen, Francisco R. Marín et al. · 2012 · European Journal of Heart Failure
6. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society.
   D. Fitchett, J. Eikelboom, S. Fremes, D. Mazer, Steve K. Singh, B. Bittira, S. Brister, J. Graham, M. Gupta, K. Karkouti et al. · 2009 · Canadian Journal of Cardiology
7. Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants
   Shima Shahjouei, Georgios K. Tsivgoulis, Nitin Goyal, Alireza Sadighi, Ashkan Mowla, Ming Wang, David Julian Seiffge, Ramin Zand · 2019 · Stroke
8. Evaluation of Cold Plasma Treatment and Safety in Disinfecting 3-week Root Canal Enterococcus faecalis Biofilm In Vitro
   Yinglong Li, Ke Sun, Guopin Ye, Yongdong Liang, Hong Pan, Guomin Wang, Yijiao Zhao, Jie Pan, Jue Zhang, Jing Fang · 2015 · Journal of Endodontics
9. Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events
   Graeme J. Hankey, John W. Eikelboom · 2010 · The Lancet Neurology
10. Efficacy and Safety of Periprocedural Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation
    Kenichi Kaseno, Shigeto Naito, Kohki Nakamura, Tamotsu Sakamoto, Takehito Sasaki, Naofumi Tsukada, Mamoru Hayano, Suguru Nishiuchi, Etsuko Fuke, Yuko Miki et al. · 2012 · Circulation Journal
11. Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?
    Gregory Y.H. Lip, Sophie K. Rushton-Smith, Samuel Zachary Goldhaber, David Andrew Fitzmaurice, Lorenzo Giovanni Mantovani, Shinya Goto, Sylvia K. Haas, Jean‐Pierre Bassand, Alan John Camm, Giuseppe Ambrosio et al. · 2015 · Circulation Cardiovascular Quality and Outcomes
12. How I treat the antiphospholipid syndrome
    Bill Giannakopoulos, Steven A. Krilis · 2009 · Blood
13. Economic Evaluation of Percutaneous Left Atrial Appendage Occlusion, Dabigatran, and Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
    Sheldon M. Singh, Andrew Micieli, Harindra Channa Wijeysundera · 2013 · Circulation
14. Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
    William J. Canestaro, Amanda R. Patrick, Jerry Avorn, Kouta Ito, Olga S. Matlin, Troyen A. Brennan, William H. Shrank, Niteesh K. Choudhry · 2013 · Circulation Cardiovascular Quality and Outcomes
15. Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke
    Nikhil Kapil, Yvonne H. Datta, Naila Alakbarova, Eric M. Bershad, Magdy H. Selim, David S. Liebeskind, Ornina Bachour, Gundu H.R. Rao, Afshin A. Divani · 2016 · Clinical and Applied Thrombosis/Hemostasis
16. Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
    Irene Savelieva, A. John Camm · 2013 · Clinical Cardiology
17. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
    Mark J. Alberts, John W. Eikelboom, Graeme J. Hankey · 2012 · The Lancet Neurology
18. Cost-Effectiveness of Outpatient Cardiac Monitoring to Detect Atrial Fibrillation After Ischemic Stroke
    Hooman Kamel, Manu Hegde, Derek R. Johnson, Brian F. Gage, S. Claiborne Johnston · 2010 · Stroke
19. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data
    Ramyashree Tummala, Ana Kavtaradze, Anjan Gupta, Raktim Kumar Ghosh · 2016 · International Journal of Cardiology
20. The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal
    María Asunción Esteve‐Pastor, Vanessa Roldán, José Miguel Rivera‐Caravaca, Inmaculada Ramírez-Macías, Gregory Y.H. Lip, Francisco R. Marín · 2019 · Thrombosis and Haemostasis
21. Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry
    Nobuhiro Murata, Yasuo Okumura, Katsuaki Yokoyama, Naoya Matsumoto, Eizo Tachibana, Keiichiro Kuronuma, Koji Oiwa, Michiaki Matsumoto, Toshiaki Kojima, Shoji Hanada et al. · 2019 · Circulation Journal
22. Outcomes for Patients with Ischaemic Stroke and Atrial Fibrillation: The PRISM Study (A Program of Research Informing Stroke Management)
    Melina Gattellari, Chris Goumas, R. John Aitken, John M. Worthington · 2011 · Cerebrovascular Diseases
23. Newer Oral Anticoagulants Should Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism
    Christopher Bull Granger, Luciana Armaganijan · 2012 · Circulation
24. Perioperative management of patients on new oral anticoagulants
    A Lai, Neil C. Davidson, Simon Galloway, Jecko V. Thachil · 2014 · British journal of surgery
25. Managing atrial fibrillation in the very elderly patient: challenges and solutions
    Κonstantinos P. Letsas, Nikolaos Karamichalakis, Konstantinos George Vlachos, Stamatis Georgopoulos, Athanasios Bakalakos, Michael Efremidis, Antonios Sideris · 2015 · Vascular Health and Risk Management
26. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study
    Karen S Sliwa, Melinda Jane Carrington, Eric Klug, Lionel Henry Opie, Geraldine Lee, Jocasta Ball, Simon Stewart · 2010 · Heart
27. Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure
    José Ramón López-Mínguez, Juan Manuel Nogales‐Asensio, Javier Elduayen Gragera, Marco Aurélio de Souza Costa, Ignacio Cruz‐González, Federico Gimeno de Carlos, José Antonio Fernández Díaz, Victoria Martín Yuste, Raúl Moreno González, Antonio J. Domínguez-Franco et al. · 2015 · Heart
28. Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease
    Koichi Kaikita, Kazuya Hosokawa, Jeffrey R. Dahlen, Kenichi Tsujita · 2019 · Thrombosis and Haemostasis
29. Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke
    Lichy Han, Mariam Askari, Russ Biagio Altman, Susan K. Schmitt, Jun Fan, Jason Bentley, Sanjiv M. Narayan, Mintu P. Turakhia · 2019 · Circulation Cardiovascular Quality and Outcomes
30. Impact of race and gender on antithrombotic therapy
    Davide Capodanno, Dominick Joseph Angiolillo · 2010 · Thrombosis and Haemostasis
31. Anticoagulants in atrial fibrillation patients with chronic kidney disease
    Robert G. Hart, John W. Eikelboom, Alistair John Ingram, Charles A. Herzog · 2012 · Nature Reviews Nephrology
32. Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation
    Hooman Kamel, J. Donald Easton, S. Claiborne Johnston, Anthony S. Kim · 2012 · Neurology
33. Novel Oral Anticoagulants in Atrial Fibrillation: A Meta‐analysis of Large, Randomized, Controlled Trials vs Warfarin
    Ariel Dogliotti, Ernesto Paolasso, Robert Patrick Giugliano · 2013 · Clinical Cardiology
34. Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)
    Mohammad Zubaid, Wafa A Rashed, Alawi A.A. Alsheikh-Ali, Wael A. Almahmeed, Abdullah Mohammed Shehab, Kadhim Sulaiman, Ibrahim S Al-Zakwani, Ahmed AlQudaimi, Nidal Asaad, Haitham Amin · 2011 · Circulation Cardiovascular Quality and Outcomes
35. Risk–Benefit Profile of Long-Term Dual- Versus Single-Antiplatelet Therapy Among Patients With Ischemic Stroke
    Meng Lee, Jeffrey L. Saver, Keun‐Sik Hong, Neal Matsumori Rao, Yi‐Ling Wu, Bruce I Ovbiagele · 2013 · Annals of Internal Medicine
36. Prevention and management of stroke in very elderly patients
    Nerses Sanossian, Bruce I Ovbiagele · 2009 · The Lancet Neurology
37. Venous Thromboembolism Prophylaxis in Critically Ill Patients
    Kochawan Boonyawat, Mark Andrew Crowther · 2015 · Seminars in Thrombosis and Hemostasis
38. Women and research on cardiovascular diseases in Europe: a report from the European Heart Health Strategy (EuroHeart) project
    Marco Stramba‐Badiale · 2010 · European Heart Journal
39. Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels
    Adedotun Ogunsua, Amir Y. Shaikh, Mohamed Ahmed, David D. McManus · 2015 · Methodist DeBakey Cardiovascular Journal
40. Cardiovascular Disease in the Elderly
    Janice B. Schwartz, Douglas Peter Zipes · 2012 · Elsevier eBooks
41. Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences
    Jeff R. Schein, Charles Michael White, Winnie W. Nelson, Jeffrey Kluger, Elizabeth S. Mearns, Craig Ian Coleman · 2016 · Thrombosis Journal
42. The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran
    Raza Alikhan, Rachel Rayment, David M. Keeling, Trevor P Baglin, Gary M. Benson, Laura Green, Scott R Marshall, Raj K. P. Patel, Sue R. Pavord, Peter E. Rose et al. · 2013 · Emergency Medicine Journal
43. Current Status of Stroke Risk Stratification in Patients With Atrial Fibrillation
    Robert G. Hart, Lesly A. Pearce · 2009 · Stroke
44. Measuring Direct Thrombin Inhibitors With Routine and Dedicated Coagulation Assays
    Joyce Curvers, Daan van de Kerkhof, An K. Stroobants, E. J. van den Dool, Volkher Scharnhorst · 2012 · American Journal of Clinical Pathology
45. Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic
    Stephanie W. Young, Lisa D. Bishop, Laurie Twells, Carla M. Dillon, John Hawboldt, Patrick G. O'Shea · 2011 · BMC Family Practice
46. Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people
    Olivier Hanon, Patrick Assayag, Joël Belmin, Jean‐Philippe Collet, J.P. Émeriau, Laurent Fauchier, Françoise Forette, Patrick Friocourt, Armelle Gentric, Christophe Leclercq et al. · 2013 · Archives of cardiovascular diseases
47. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
    Bülent Görenek, Carina Blomström Lundqvist, Josép Brugada, Alan John Camm, Gerhard Hindricks, Kurt Huber, Paulus F. Kirchhof, Karl‐Heinz Kück, Gulmira Kudaiberdieva, Tina Lin et al. · 2015 · EuroIntervention
48. Antiplatelet Treatment for Prevention of Cerebrovascular Events in Patients With Vascular Diseases
    Ghazaleh Gouya, Jasmin Arrich, Michael Wolzt, Kurt Huber, Freek W.A. Verheugt, Paul Alfred Gurbel, Agnes Pirker-Kees, Jolanta Maria Siller-Matula · 2013 · Stroke
49. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm
    Piotr P. Ponikowski, Felicita Andreotti, Stefan D. Anker, Gerasimos Filippatos, Shunichi Homma, João Morais, Patrick M. Pullicino, Lars Rasmussen, Francisco R. Marín, Deirdre A. Lane et al. · 2012 · Thrombosis and Haemostasis
50. Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation
    Craig Ian Coleman, Diana M Sobieraj, Sara Winkler, P. Cutting, M. Mediouni, Sabina Alikhanov, Jeffrey Kluger · 2011 · International Journal of Clinical Practice
51. New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism
    Agon Mekaj, Ymer Mekaj, Daci FT · 2015 · Therapeutics and Clinical Risk Management
52. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations
    Jeff S. Healey, Ratika Parkash, Tim Pollak, Teresa S.M. Tsang, Paul Dorian · 2011 · Canadian Journal of Cardiology
53. Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
    Marco Metra, Valerio Zacà, Gianfranco Parati, Piergiuseppe Agostoni, Maria Bonadies, Marco Matteo Ciccone, Alessandra Dei, Massimo Iacoviello, Rocco Lagioia, Carolina Lombardi et al. · 2010 · Journal of Cardiovascular Medicine
54. Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation
    CAROLINE MEDI, Graeme J. Hankey, Saul B. Freedman · 2010 · Stroke
55. Novel oral anticoagulants and reversal agents: Considerations for clinical development
    Troy C. Sarich, Jonathan H. Seltzer, Scott D. Berkowitz, James C. Costin, John T. Curnutte, Charles Michael Gibson, Maureane Hoffman, Edvardas Kaminskas, Mitchell W. Krucoff, Jerrold H. Levy et al. · 2015 · American Heart Journal
56. Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation
    Adrian Matthew Shields, Gregory Y.H. Lip · 2015 · Journal of Internal Medicine
57. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban
    Adewale Alade Fawole, Hamed A. Daw, Mark Andrew Crowther · 2013 · Cleveland Clinic Journal of Medicine
58. Women with atrial fibrillation: Greater risk, less attention
    Annabelle Santos Volgman, Marian F. Manankil, Disha Mookherjee, Richard G. Trohman · 2009 · Gender Medicine
59. Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation
    John W. Eikelboom, Stuart J. Connolly, Robert G. Hart, Lars C. Wallentin, Paul A. Reilly, Jonas Oldgren, Sean Yang, Salim Yusuf · 2013 · Journal of the American College of Cardiology
60. Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options
    Bruce Sheldon Stambler, Leonard Mzee Ngunga · 2015 · International Journal of General Medicine
61. A semi‐mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin
    Xavier Delavenne, Édouard Ollier, Thierry Basset, Laurent Bertoletti, Sandrine Accassat, Arnauld Garcin, Silvy Laporte, Paul Jacques Zufferey, Patrick Mismetti · 2012 · British Journal of Clinical Pharmacology
62. Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation
    Greg C. Flaker, Michael D. Ezekowitz, Salim Yusuf, Lars C. Wallentin, Herbert Noack, Martina Brueckmann, Paul A. Reilly, Stefan Hans Hohnloser, Stuart J. Connolly · 2012 · Journal of the American College of Cardiology
63. Reversal of drug‐induced anticoagulation: old solutions and new problems
    Sunny Dzik · 2012 · Transfusion
64. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: Implications for emergency surgery and resuscitation
    Martine Wolf, Lilia Soufir, Arnaud Galbois, Anne-Sylvie Dumenil, Georges Offenstadt, Meyer‐Michel Samama, Agnés Lillo‐Le Louët · 2012 · Thrombosis and Haemostasis
65. The Impact of Heart Failure and Left Ventricular Dysfunction in Predicting Stroke, Thromboembolism, and Mortality in Atrial Fibrillation Patients: A Systematic Review
    Megha Agarwal, Stavros Z. Apostolakis, Deirdre A. Lane, Gregory Y.H. Lip · 2014 · Clinical Therapeutics
66. Essential Topics About the Imaging Diagnosis and Treatment of Hemorrhagic Stroke: A Comprehensive Review of the 2022 AHA Guidelines
    Cesar-Alejandro Gil-García, Eduardo Flores-Álvarez, Ricardo Cebrian-Garcia, Abril-Carolina Mendoza-Lopez, Leslie-Marisol González-Hermosillo, Maria-del-Carmen Garcia-Blanco, Ernesto Roldán-Valadéz · 2022 · Current Problems in Cardiology
67. Atherothrombosis and atrial fibrillation: Important and often overlapping clinical syndromes
    Jeremiah Peter Depta, Deepak L. Bhatt · 2010 · Thrombosis and Haemostasis
68. The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey
    Mauro Molteni, Hernan Polo Friz, L. Primitz, Giuseppe Marano, Patrizia Boracchi, Claudio Cimminiello · 2014 · EP Europace
69. Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues
    Stephanie A. Ross, Sonia Savitri Anand, Philip G. Joseph, Guillaume Paré · 2012 · JRSM Cardiovascular Disease
70. Forecasting drug utilization and expenditure in a metropolitan health region
    Björn Wettermark, Marie E Persson, Nils Erik Wilking, Mats Kalin, Seher Korkmaz, Paul Hjemdahl, Brian Godman, Max Petzold, Lars Lennart Gustafsson · 2010 · BMC Health Services Research
71. Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Stephan Henrik Schirmer, Magnus Baumhäkel, Hans‐Ruprecht Neuberger, Stefan Hans Hohnloser, Isabelle C. Van Gelder, Gregory Y.H. Lip, Michael Böhm · 2010 · Journal of the American College of Cardiology
72. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink
    Ana Filipa Macedo, James Bell, C. McCarron, Rachel Conroy, James Richardson, Anna Scowcroft, Tom Sunderland, Naj Rotheram · 2015 · Thrombosis Research
73. New oral anticoagulants: a practical guide for physicians
    Rocío Hinojar, Jose Julio Jiménez-Natcher, Covadonga Fernández‐Golfín, José Luis Zamorano · 2015 · European Heart Journal - Cardiovascular Pharmacotherapy
74. Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non–Vitamin K Antagonist Oral Anticoagulants Before Stroke
    Ying Xian, Jerome Jeffrey Federspiel, Adrian F. Hernandez, Daniel T. Laskowitz, Lee H. Schwamm, Deepak L. Bhatt, Eric Edward Smith, Gregg C. Fonarow, Eric David Peterson · 2017 · Circulation
75. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran
    María Consuelo Matute, Marta Guillán, Juan García‐Caldentey, Javier Buisán, M Aparicio, Jaime Masjuán, María Alonso de Leciñana · 2011 · Thrombosis and Haemostasis
76. Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta‐Analysis
    Larisa G. Tereshchenko, Charles A. Henrikson, Joaquin E. Cigarroa, Jonathan S. Steinberg · 2016 · Journal of the American Heart Association
77. Meta-Analysis of the Influence of Chronic Kidney Disease on the Risk of Thromboembolism Among Patients With Nonvalvular Atrial Fibrillation
    Rui Andre Providencia, Éloi Marijon, Serge Bovéda, Sérgio Barra, Kumar Narayanan, Jean‐Yves Le Heuzey, Bernard John Gersh, Lino Manuel Martins Gonçalves · 2014 · The American Journal of Cardiology
78. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)
    Kevin L. Thomas, Larry R. Jackson, Peter Shrader, Jack Ansell, Gregg C. Fonarow, Bernard John Gersh, Peter Russell Kowey, Kenneth W. Mahaffey, Daniel E. Singer, Laine Elliott Thomas et al. · 2017 · Journal of the American Heart Association
79. Increasing incidence of chronic subdural haematoma in the elderly
    Vedamurthy Adhiyaman, I Chatterjee · 2017 · QJM
80. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence
    Tullio Palmerini, Gregg W. Stone · 2016 · European Heart Journal
81. Factors Driving Anticoagulant Selection in Patients With Atrial Fibrillation in the United States
    Julie C. Lauffenburger, Joel F. Farley, Anil K. Gehi, Denise H. Rhoney, M. Alan Brookhart, Gang Fang · 2015 · The American Journal of Cardiology
82. Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients
    Ariel Dogliotti, Ernesto Paolasso, Robert Patrick Giugliano · 2013 · Heart
83. Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin
    Álvaro Alonso, Lindsay G.S. Bengtson, Richard F. MacLehose, Pamela L. Lutsey, Lin Y. Chen, Kamakshi Lakshminarayan · 2014 · Stroke
84. Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
    Luigi Di Biase · 2016 · Journal of the American Heart Association
85. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care
    Richard F. Hobbs, Clare J Taylor, Geert Jan Geersing, Frans Hendrik Rutten, Judith Rixt Brouwer, on behalf of the European Primary Care Cardiovascular Society (EPCCS) SPAF working group · 2015 · European Journal of Preventive Cardiology
86. Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate*
    Margareta Blombäck, Shu He, Niklas Bark, Håkan Wallén, Margareta Elg · 2011 · British Journal of Haematology
87. The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage
    Jamil R. Dibu, Jonathan M. Weimer, Christine L. Ahrens, Edward M. Manno, Jennifer Ann Frontera · 2015 · Neurocritical Care
88. Individual variability in the disposition of and response to clopidogrel: Pharmacogenomics and beyond
    Hong‐Guang Xie, Jianjun Zou, Zuo‐Ying Hu, Junjie Zhang, Fei Ye, Shao‐Liang Chen · 2010 · Pharmacology & Therapeutics
89. Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation
    Anders Nissen Bonde, Gregory Y.H. Lip, Anne‐Lise Kamper, Emil Loldrup Fosbøl, Laila Stærk, Nicholas Carlson, Christian Tobias Torp-Pedersen, Gunnar Gislason, Jonas Bjerring Olesen · 2016 · Stroke
90. New anticoagulants: how to deal with treatment failure and bleeding complications
    Rashid Saeed Kazmi, Bashir Abdulgader Lwaleed · 2011 · British Journal of Clinical Pharmacology
91. Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)
    Rangadham Nagarakanti, Lars C. Wallentin, Herbert Noack, Martina Brueckmann, Paul A. Reilly, Andreas Clemens, Stuart J. Connolly, Salim Yusuf, Michael D. Ezekowitz · 2015 · The American Journal of Cardiology
92. Thrombi of Different Pathologies: Implications for Diagnosis and Treatment
    Carlos G. Santos‐Gallego, Jeremías Bayón, Juan J. Badimón · 2010 · Current Treatment Options in Cardiovascular Medicine
93. Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack
    Priyesh Ashok Patel, Xin Zhao, Gregg C. Fonarow, Barbara L. Lytle, Eric Edward Smith, Ying Xian, Deepak L. Bhatt, Eric David Peterson, Lee H. Schwamm, Adrian F. Hernandez · 2015 · Circulation Cardiovascular Quality and Outcomes
94. Experimental research Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice
    Simon Pingel, Vedat Tiyerili, Jens Mueller, Nikos Werner, Georg Nickenig, Cornelius F.H. Mueller · 2014 · Archives of Medical Science
95. Management of postoperative atrial fibrillation
    Takeshi Omae, Yuichi Kanmura · 2012 · Journal of Anesthesia
96. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: A review of the literature
    Cecilia Becattini, Maria Cristina Vedovati, Giancarlo Agnelli · 2012 · Thrombosis Research
97. Systematic review and network meta-analysis of stroke-prevention treatments in patients with atrial fibrillation
    Amy Tawfik, JOANNA M. BIELECKI, Murray Dale Krahn, Paul Dorian, Jeffrey S. Hoch, Heather Shirley Boon, Don Husereau, Petros Pechlivanoglou · 2016 · Clinical Pharmacology Advances and Applications
98. Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction
    Javier Alfonso Valle, Susan M. Shetterly, Thomas M. Maddox, P. Michael Ho, Steven M. Bradley, Amneet Sandhu, David J. Magid, Thomas T. Tsai · 2016 · Circulation Cardiovascular Interventions
99. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life
    Cecilia Becattini, Laura Franco, Jan Beyer‐Westendorf, Luca Masotti, Cinzia Nitti, Simone Vanni, Giorgia Manina, Sergio Cattinelli, Roberto Cappelli, Rodolfo Sbrojavacca et al. · 2016 · International Journal of Cardiology
100. Atrial Fibrillation
     A. John Camm, Irina Savelieva, Siew Yen Ho, Bruce D. Lindsay, Stanley Nattel, Kaori Shinagawa · 2009 · Elsevier eBooks